Xufang Dai

847 total citations
27 papers, 651 citations indexed

About

Xufang Dai is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Xufang Dai has authored 27 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Epidemiology and 6 papers in Cancer Research. Recurrent topics in Xufang Dai's work include Autophagy in Disease and Therapy (11 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Cell death mechanisms and regulation (5 papers). Xufang Dai is often cited by papers focused on Autophagy in Disease and Therapy (11 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Cell death mechanisms and regulation (5 papers). Xufang Dai collaborates with scholars based in China, United States and Macao. Xufang Dai's co-authors include Jiqin Lian, Fengtian He, Zhenhong Ni, Liang Xu, Xinzhe Li, Xiaojing Yan, Yaran Wu, Amber R. Smith, Bin Wang and Bin Wang and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Xufang Dai

25 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xufang Dai China 14 434 242 148 76 64 27 651
Nicolas Kuperwasser France 11 554 1.3× 171 0.7× 93 0.6× 112 1.5× 63 1.0× 14 848
Yanyan Peng United States 21 668 1.5× 84 0.3× 110 0.7× 91 1.2× 49 0.8× 40 952
Bryant J. Gavino United States 8 839 1.9× 67 0.3× 83 0.6× 132 1.7× 90 1.4× 9 1.0k
Annalisa Mupo United Kingdom 12 788 1.8× 117 0.5× 65 0.4× 20 0.3× 155 2.4× 22 1000
Samisubbu R. Naidu United States 13 405 0.9× 129 0.5× 86 0.6× 18 0.2× 69 1.1× 18 594
Esther Seco Spain 6 457 1.1× 347 1.4× 136 0.9× 78 1.0× 16 0.3× 7 695
Wataru Nakajima Japan 13 400 0.9× 112 0.5× 131 0.9× 81 1.1× 25 0.4× 28 592
Ken Hayashi Japan 14 625 1.4× 125 0.5× 98 0.7× 358 4.7× 80 1.3× 24 947
Silvia Vega-Rubín-de-Celis Germany 12 611 1.4× 519 2.1× 164 1.1× 189 2.5× 25 0.4× 20 1.0k
R. Miceli United States 14 485 1.1× 68 0.3× 106 0.7× 26 0.3× 64 1.0× 19 865

Countries citing papers authored by Xufang Dai

Since Specialization
Citations

This map shows the geographic impact of Xufang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufang Dai more than expected).

Fields of papers citing papers by Xufang Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufang Dai. The network helps show where Xufang Dai may publish in the future.

Co-authorship network of co-authors of Xufang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xufang Dai. A scholar is included among the top collaborators of Xufang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufang Dai. Xufang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Ming, Dong Liu, Lingxi Chen, et al.. (2025). Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy. Cell Death and Differentiation. 32(9). 1630–1647. 1 indexed citations
2.
Dai, Xufang, Yanbing Chen, Chengheng Wu, et al.. (2025). Hybrid Lipoplex Boosts Neuron‐Microglia Crosstalk for Treatment of Alzheimer's Disease through A β ‐Targeted‐Autophagy and ApoE2 Gene Supplementation. Advanced Materials. 37(27). e2418560–e2418560. 3 indexed citations
3.
Zhang, Shaotong, Yaran Wu, Xufang Dai, et al.. (2025). Local delivery of IL-15 and anti-PD-L1 nanobody by in vitro-transcribed circILNb elicits superior antitumor immunity in cold tumors. Cell Reports Medicine. 6(10). 102413–102413.
4.
Zeng, Rong, Meng He, Xufang Dai, et al.. (2024). Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect. Biochemical Pharmacology. 227. 116419–116419. 6 indexed citations
5.
Zhang, Yueting, et al.. (2024). Chronic administration of low dose aspirin alleviates ASD-like behaviors and activates AMPK in valproic acid-exposed rats. Research in autism spectrum disorders. 118. 102499–102499.
6.
He, Meng, Dong Liu, Xufang Dai, et al.. (2023). Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells. Biochemical Pharmacology. 211. 115538–115538. 5 indexed citations
7.
Xiong, Haojun, Xufang Dai, Xiaojing Yan, et al.. (2022). Deacetylation of ATG4B promotes autophagy initiation under starvation. Science Advances. 8(31). eabo0412–eabo0412. 30 indexed citations
8.
Yan, Xiaojing, Xufang Dai, Chen Huang, et al.. (2021). Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells. Experimental Cell Research. 406(1). 112755–112755. 13 indexed citations
9.
Dai, Xufang, Tao Li, Xiaojing Yan, et al.. (2021). LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells. Frontiers in Cell and Developmental Biology. 9. 687524–687524. 30 indexed citations
10.
Yan, Xiaojing, Peng Xie, Xufang Dai, et al.. (2020). Dichloroacetate enhances the antitumor effect of pirarubicin via regulating the ROS-JNK signaling pathway in liver cancer cells. Cancer Drug Resistance. 3(4). 947–958. 3 indexed citations
11.
Dai, Xufang, et al.. (2017). Valproic acid exposure decreases the mRNA stability of Bcl-2 via up-regulating miR-34a in the cerebellum of rat. Neuroscience Letters. 657. 159–165. 13 indexed citations
12.
Dai, Xufang, et al.. (2016). Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats. Molecular and Cellular Neuroscience. 75. 27–35. 69 indexed citations
13.
Dai, Xufang, et al.. (2015). [Effect of sulindac on improving autistic behaviors in rats].. PubMed. 35(8). 1162–5. 2 indexed citations
14.
Ni, Zhenhong, Yi Gong, Xufang Dai, et al.. (2015). AU4S: A novel synthetic peptide to measure the activity of ATG4 in living cells. Autophagy. 11(2). 403–415. 20 indexed citations
15.
Ni, Zhenhong, Bin Wang, Xufang Dai, et al.. (2014). HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS–JNK–autophagy pathway. Free Radical Biology and Medicine. 70. 194–203. 73 indexed citations
16.
Wang, Bin, Lin‐Feng Chen, Zhenhong Ni, et al.. (2014). Hsp90 inhibitor 17-AAG sensitizes Bcl-2 inhibitor (-)-gossypol by suppressing ERK-mediated protective autophagy and Mcl-1 accumulation in hepatocellular carcinoma cells. Experimental Cell Research. 328(2). 379–387. 29 indexed citations
17.
Ni, Zhenhong, Xufang Dai, Bin Wang, et al.. (2013). Natural Bcl-2 inhibitor (−)– gossypol induces protective autophagy via reactive oxygen species–high mobility group box 1 pathway in Burkitt lymphoma. Leukemia & lymphoma. 54(10). 2263–2268. 23 indexed citations
18.
Cheng, Ping, Zhenhong Ni, Xufang Dai, et al.. (2013). The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma cells. Cell Death and Disease. 4(2). e489–e489. 81 indexed citations
19.
Lian, Jiqin, Zhenhong Ni, Xufang Dai, et al.. (2011). Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation. Molecular Cancer Therapeutics. 11(2). 416–426. 42 indexed citations
20.
Lian, Jiqin, Xufang Dai, Xiaohui Li, & Fengtian He. (2006). Identification of an active site on the laminin α4 chain globular domain that binds to αvβ3 integrin and promotes angiogenesis. Biochemical and Biophysical Research Communications. 347(1). 248–253. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Kuperwasser Breakdown of academic impact, for papers by Yanyan Peng Breakdown of academic impact, for papers by Bryant J. Gavino Breakdown of academic impact, for papers by Annalisa Mupo Breakdown of academic impact, for papers by Samisubbu R. Naidu Breakdown of academic impact, for papers by Esther Seco Breakdown of academic impact, for papers by Wataru Nakajima Breakdown of academic impact, for papers by Ken Hayashi Breakdown of academic impact, for papers by Silvia Vega-Rubín-de-Celis Breakdown of academic impact, for papers by R. Miceli
Rankless by CCL
2026